Latest & greatest articles for Amnioinfusion

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Amnioinfusion or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Amnioinfusion and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Amnioinfusion

1. Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial (Abstract)

Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial To assess the effectiveness of amnioinfusion in women with second-trimester preterm prelabor rupture of membranes.We performed a nationwide, multicenter, open-label, randomized controlled trial, the PPROM: Expectant Management versus Induction of Labor-III (PPROMEXIL-III) trial, in women with singleton pregnancies and preterm prelabor rupture of membranes at 16 0/7 (...) to 24 0/7 weeks of gestation with oligohydramnios (single deepest pocket less than 20 mm). Participants were allocated to transabdominal amnioinfusion or no intervention in a one-to-one ratio by a web-based system. If the single deepest pocket was less than 20 mm on follow-up visits, amnioinfusion was repeated weekly until 28 0/7 weeks of gestation. The primary outcome was perinatal mortality. We needed 56 women to show a reduction in perinatal mortality from 70% to 35% (β error 0.20, two-sided α

2019 EvidenceUpdates

2. Amnioinfusion for chorioamnionitis. Full Text available with Trip Pro

Amnioinfusion for chorioamnionitis. Chorioamnionitis is a leading cause of perinatal morbidity and mortality. Amnioinfusion aims at reducing the adverse effects of chorioamnionitis by dilution of the infective organisms or by an anti-microbial effect of the fluid infused.The objective of this review was to determine the effect of amnioinfusion on clinical and sub-clinical chorioamnionitis, fetal well-being, fetal heart rate characteristics and perinatal and maternal morbidity and mortality.We (...) searched the Cochrane Pregnancy and Childbirth Group's Trials Register (6 July 2016), PubMed, ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (6 July 2016) and reference lists of retrieved studies.Randomised clinical trials (RCTs) of amnioinfusion (treatment group) versus no amnioinfusion in women with chorioamnionitis.We would have also considered trials comparing amnioinfusion with sham amnioinfusion; different types or volumes of amnioinfusion fluid but none were

2016 Cochrane

3. Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks. Full Text available with Trip Pro

Transabdominal amnioinfusion for improving fetal outcomes after oligohydramnios secondary to preterm prelabour rupture of membranes before 26 weeks. Preterm prelabour rupture of membranes (PPROM) before 26 weeks can delay lung development and can cause pulmonary hypoplasia, as a result of oligohydramnios. Restoring the amniotic fluid volume by transabdominal amnioinfusion might prevent abnormal lung development and might have a protective effect for neurological complications, fetal deformities (...) and neonatal sepsis.To assess the effectiveness of transabdominal amnioinfusion in improving perinatal outcome in women with oligohydramnios secondary to rupture of fetal membranes before 26 weeks.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2013).All randomised controlled trials comparing transabdominal amnioinfusion with no transabdominal amnioinfusion. Cluster- or quasi-randomised trials were not eligible for inclusion. In cases where only an abstract was available

2013 Cochrane

4. Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. Full Text available with Trip Pro

Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. Amnioinfusion aims to relieve umbilical cord compression during labour by infusing a liquid into the uterine cavity.The objective of this review was to assess the effects of prophylactic amnioinfusion for women in labour with oligohydramnios, but not fetal heart deceleration, compared with therapeutic amnioinfusion only if fetal heart rate decelerations or thick meconium-staining of the liquor occur.We searched (...) the Cochrane Pregnancy and Childbirth Group's Trials Register (28 February 2012).Randomised trials comparing prophylactic amnioinfusion in women in labour with oligohydramnios but not fetal heart rate deceleration in labour with therapeutic amnioinfusion.The authors assessed trial quality and extracted data.One randomized trial of 116 women was included. No differences were found in the rate of caesarean section (risk ratio 1.29, 95% confidence interval 0.60 to 2.74). There were no differences in cord

2012 Cochrane

5. WITHDRAWN: Amnioinfusion for meconium-stained liquor in labour. (Abstract)

WITHDRAWN: Amnioinfusion for meconium-stained liquor in labour. Amnioinfusion aims to prevent or relieve umbilical cord compression during labour by infusing a solution into the uterine cavity. It is also thought to dilute meconium when present in the amniotic fluid and so reduce the risk of meconium aspiration. However, it may be that the mechanism of effect is that it corrects oligohydramnios (reduced amniotic fluid), for which thick meconium staining is a marker.The objective of this review (...) was to assess the effects of amnioinfusion for meconium-stained liquor on perinatal outcome.The Cochrane Pregnancy and Childbirth Group trials register (October 2001) and the Cochrane Controlled Trials Register (Issue 3, 2001) were searched.Randomised trials comparing amnioinfusion with no amnioinfusion for women in labour with moderate or thick meconium-staining of the amniotic fluid.Eligibility and trial quality were assessed by one reviewer.Twelve studies, most involving small numbers of participants

2009 Cochrane

6. Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials

Intrapartum amnioinfusion for meconium-stained amniotic fluid: a systematic review of randomised controlled trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

7. Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) (IPG192)

Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) (IPG192) Overview | Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) | Guidance | NICE Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) Interventional procedures guidance [IPG192] Published date: November 2006 Share Save Guidance The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales (...) , Scotland and Northern Ireland on therapeutic amnioinfusion for oligohydramnios during pregnancy in November 2006. In accordance with the Interventional Procedures Programme Process Guide, guidance on procedures with special arrangements are reviewed 3 years after publication and the procedure is reassessed if important new evidence is available. The guidance was considered for reassessment in November 2009 and it was concluded that NICE will not be updating this guidance at this stage. However, if you

2006 National Institute for Health and Clinical Excellence - Interventional Procedures

8. Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour)

Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) National Institute for Health and Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National (...) Institute for Health and Clinical Excellence. Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) London: National Institute for Health and Clinical Excellence (NICE). Interventional Procedure Guidance 192. 2006 Authors' objectives This study aims to assess the current evidence on therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour). Authors' conclusions 1 Guidance 1.1 Current evidence on the safety and efficacy of therapeutic amnioinfusion

2006 Health Technology Assessment (HTA) Database.

9. Amnioinfusion for the prevention of the meconium aspiration syndrome. (Abstract)

Amnioinfusion for the prevention of the meconium aspiration syndrome. It is uncertain whether amnioinfusion (infusion of saline into the amniotic cavity) in women who have thick meconium staining of the amniotic fluid reduces the risk of perinatal death, moderate or severe meconium aspiration syndrome, or both.We performed a multicenter trial in which 1998 pregnant women in labor at 36 or more weeks of gestation who had thick meconium staining of the amniotic fluid were stratified according (...) to the presence or absence of variable decelerations in fetal heart rate and then randomly assigned to amnioinfusion or to standard care. The composite primary outcome measure was perinatal death, moderate or severe meconium aspiration syndrome, or both.Perinatal death, moderate or severe meconium aspiration syndrome, or both occurred in 44 infants (4.5 percent) of women in the amnioinfusion group and 35 infants (3.5 percent) of women in the control group (relative risk, 1.26; 95 percent confidence interval

2005 NEJM Controlled trial quality: predicted high

10. Amnioinfusion for umbilical cord compression in labour. (Abstract)

Amnioinfusion for umbilical cord compression in labour. Amnioinfusion aims to prevent or relieve umbilical cord compression during labour by infusing a solution into the uterine cavity.The objective of this review was to assess the effects of amnioinfusion on maternal and perinatal outcome for potential or suspected umbilical cord compression or potential amnionitis.The Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register were searched.Randomised (...) trials of amnioinfusion compared with no amnioinfusion in women with babies at risk of umbilical cord compression; and women at risk of intrauterine infection.Eligibility and trial quality were assessed by the reviewer.Twelve studies were included. Transcervical amnioinfusion for potential or suspected umbilical cord compression was associated with the following reductions: fetal heart rate decelerations (relative risk 0.54, 95% confidence interval 0.43 to 0.68); caesarean section for suspected fetal

2000 Cochrane

11. Amnioinfusion for meconium-stained liquor in labour. (Abstract)

Amnioinfusion for meconium-stained liquor in labour. Amnioinfusion aims to prevent or relieve umbilical cord compression during labour by infusing a solution into the uterine cavity. It is also thought to dilute meconium when present in the amniotic fluid and so reduce the risk of meconium aspiration. However it may be that the mechanism of effect is that it corrects oligohydramnios (reduced amniotic fluid), for which thick meconium staining is a marker.The objective of this review (...) was to assess the effects of amnioinfusion for meconium-stained liquor on perinatal outcome.The Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register were searched.Randomised trials comparing amnioinfusion with no amnioinfusion for women in labour with moderate or thick meconium-staining of the amniotic fluid.Eligibility and trial quality were assessed by one reviewer.Ten studies, most involving small numbers of participants, were included. Under standard

2000 Cochrane

12. Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. (Abstract)

Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour. Amnioinfusion aims to relieve umbilical cord compression during labour by infusing a liquid into the uterine cavity.The objective of this review was to assess the effects of prophylactic amnioinfusion for oligohydramnios compared with therapeutic amnioinfusion only if fetal heart rate decelerations or thick meconium-staining of the liquor occur.The Cochrane Pregnancy and Childbirth Group trials register and Cochrane (...) Controlled Trials Register were searched. Date of last search: October 1997.Randomised trials comparing prophylactic with therapeutic amnioinfusion in women with oligohydramnios but not fetal heart rate deceleration in labour.The reviewer assessed trial quality and extracted data.Two studies of 285 women were included. No differences were found in the rate of caesarean section (relative risk 0.98, 95% confidence interval 0.58 to 1.66), or forceps delivery. There were no difference in Apgar scores, cord

2000 Cochrane

13. Amnioinfusion for preterm rupture of membranes. (Abstract)

Amnioinfusion for preterm rupture of membranes. Preterm rupture of membranes places a fetus at risk of cord compression and amnionitis. Amnioinfusion aims to prevent or relieve umbilical cord compression by infusing a solution into the uterine cavity.The objective of this review was to assess the effects of amnioinfusion for preterm rupture of membranes on maternal and perinatal outcomes.The Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register were (...) searched.Randomised trials of amnioinfusion compared to no amnioinfusion in women with preterm rupture of membranes.Eligibility and trial quality were assessed by the reviewer.One trial of 66 women was included. It had some methodological flaws. No significant differences between amnioinfusion and no amnioinfusion were detected for caesarean section (relative risk 0.32, 95% confidence interval 0.07 to 1.40); low Apgar scores (relative risk 0.28, 95% confidence interval 0.03 to 2.33) or neonatal death (relative

2000 Cochrane

14. Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials

Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials Intrapartum amnioinfusion for meconium-stained fluid: meta-analysis of prospective clinical trials Pierce J, Gaudier F L, Sanchez-Ramos L Authors' objectives To evaluate the effectiveness of intrapartum prophylactic amnioinfusion in pregnancies complicated by meconium-stained amniotic fluid (AF (...) ). Searching MEDLINE and PubMed were searched from January 1980 to December 1998 using the search terms 'amnioinfusion' and 'meconium'. The authors also checked the references of published articles and chapters from textbooks. Any restrictions on the publication language were not stated. Abstracts were included in the analysis, whereas unpublished trials and data were not. Study selection Study designs of evaluations included in the review Prospective clinical trials were included. Specific interventions

2000 DARE.

15. Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials

Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials Prophylactic amnioinfusion for intrapartum oligohydramnios: a meta-analysis of randomized controlled trials Pitt C, Sanchez-Ramos L, Kaunitz A M, Gaudier F Authors' objectives To evaluate the effectiveness of intrapartum prophylactic amnioinfusion in pregnancies complicated (...) by oligohydramnios. Searching The following sources were searched from January 1983 to December 1999: BRS online (Bibliographic Retrieval Service), MEDLINE, PubMed, Current Contents, and other databases via SilverPlatter. The MeSH terms used were 'amnioinfusion', 'oligohydramnios' and 'fetal compromise'. Bibliographies from identified studies and review articles were examined for articles published in any language. Abstracts were eligible for inclusion, whereas unpublished trials and review articles were

2000 DARE.

16. The effect of amnioinfusion on the duration of labor

The effect of amnioinfusion on the duration of labor The effect of amnioinfusion on the duration of labor The effect of amnioinfusion on the duration of labor Strong T H Authors' objectives To test the hypothesis that women receiving intrapartum amniotransfusion have more rapid labours than do controls, and to determine if amniotransfusion affects the duration of labour. Searching MEDLINE was searched for trials published in three major American obstetric and gynaecologic journals. A manual (...) the interval from membrane rupture to delivery (283 infusions, 241 control patients), whilst eight studies evaluated the length of labour (382 transfusions, 349 control patients). No study demonstrated a statistically significant shortening of the amniorrhexis to delivery interval or the overall duration of labour. The meta-analysis revealed no difference in the interval from membrane rupture to delivery (p=0.23) or the total length of labour (p=0.35). Authors' conclusions Amnioinfusion has no effect

1997 DARE.

17. Pumps and warmers during amnioinfusion: is either necessary?

Pumps and warmers during amnioinfusion: is either necessary? Pumps and warmers during amnioinfusion: is either necessary? Pumps and warmers during amnioinfusion: is either necessary? Glantz J C, Letteney D L Authors' objectives To determine whether infusion pumps or solution warmers are associated with improved maternal or neonatal outcome during amnioinfusion. Searching MEDLINE was searched from 1983 (the earliest year in which trials of amnioinfusion in humans were reported) to 1994 (...) , and the references of published articles were examined. Study selection Study designs of evaluations included in the review Prospective studies with a control group (randomised and non-randomised trials) were included. Specific interventions included in the review The use of infusion pumps or solution warmers during amnioinfusion. Participants included in the review Pregnant women were included. Outcomes assessed in the review Maternal and neonatal outcomes: Caesarean delivery, foetal distress, presence

1996 DARE.